Stocks · Healthcare · Biotechnology
Clene Inc. CLNN
$4.08 +1.49% Close, Oct 2, 2026 · NASDAQ · Market cap $52.1M
Weak trendExpensive vs sectorHigh risk
Next earnings report: Nov 12, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -10304.6% from -9234.3% a year earlier.
- The diluted share count rose 30.0% in a year.
- The stock is 67% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 14%
- Revenue growth, 3-year CAGRBottom 7%
- Revenue growth accelerationTop 6%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 9%
- Gross marginBottom 6%
- Operating marginBottom 4%
- Accruals (lower is better)Top 2%
- Interest coverBottom 37%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 8%
- Free-cash-flow yieldBottom 16%
- EBITDA / enterprise valueBottom 16%
- Sales / enterprise valueBottom 5%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 10%
- 6-month returnBottom 24%
- 1-year return vs S&P 500Bottom 14%
- Distance from 52-week highBottom 9%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 11%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 31%
- Upside to consensus price targetTop 1%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 18%
- Maximum drawdown, 3 yearsBottom 37%
- Beta vs S&P 500 (lower is better)Bottom 14%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -61.7% | -31.1% | ↑ |
| Gross margin | 80.4% | -110.2% | ↓ |
| Operating margin | -9234.3% | -10304.6% | ↓ |
| FCF margin | -6169.6% | -8103.5% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -31.1% | -61.7% | ↑ | Bottom 14% |
| Gross margin | -110.2% | 80.4% | ↓ | Bottom 6% |
| Operating margin | -10304.6% | -9234.3% | ↓ | Bottom 4% |
| Net margin | -20059.9% | -10386.4% | ↓ | — |
| Free-cash-flow margin | -8103.5% | -6169.6% | ↓ | — |
| Return on invested capital | -104.5% | — | Bottom 9% | |
| Revenue growth, 3-year CAGR | -24.9% | — | Bottom 7% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -102.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 3615.7%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +20.8 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -7.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -13.02%
- Shareholder yield
- -13.02%
- Share count change, 1 year
- +30.0%
- Share count change, 3-year CAGR
- +42.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 14, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- -74.7%
- Average 2-day reaction, last 8
- -4.4%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $50.00
- Target vs current price
- +1125.5%
- Analysts with a rating
- 8
- Share rating Buy or Strong Buy
- 88%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 14, 2026 | -193.5% | -1.2% | +4.3% | -14.8% | — |
| May 14, 2026 | -38.0% | +8.5% | +6.2% | -14.9% | -20.6% |
| Mar 12, 2026 | -25.7% | +6.1% | +17.7% | +13.6% | -2.3% |
| Nov 13, 2025 | -41.7% | -22.4% | -8.1% | -26.9% | -53.0% |
| Aug 14, 2025 | -59.2% | -1.4% | +54.0% | +69.3% | +153.4% |
| May 7, 2025 | +90.5% | -10.5% | -7.4% | +41.1% | +22.5% |
| Mar 24, 2025 | -38.0% | -5.3% | -22.2% | -27.1% | +2.2% |
| Nov 13, 2024 | +7.6% | -9.1% | -12.1% | -6.2% | -13.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 14, 2026 | -$1.08 | -$0.37 | -193.5% | $90,000 |
| May 14, 2026 | -$0.69 | -$0.50 | -38.0% | $15,000 |
| Mar 12, 2026 | -$0.93 | -$0.74 | -25.7% | $77,000 |
| Nov 13, 2025 | -$0.85 | -$0.60 | -41.7% | $15,000 |
| Aug 14, 2025 | -$0.78 | -$0.49 | -59.2% | $27,000 |
| May 7, 2025 | -$0.09 | -$0.95 | +90.5% | $81,000 |
| Mar 24, 2025 | -$1.67 | -$1.21 | -38.0% | $91,000 |
| Nov 13, 2024 | -$1.22 | -$1.32 | +7.6% | $87,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 328.98× | — | — | Bottom 5% |
| Free-cash-flow yield | -30.62% | — | — | Bottom 16% |
| Earnings yield | -87.01% | — | — | Bottom 8% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -15.5%
- 200-day average slope (20 days)
- -6.8%
- Distance from 50-day average
- -6.9%
- Distance from 200-day average
- -24.6%
- RSI (14)
- 47.1
- Relative volume
- 0.42×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 79.6%
- Volatility vs own 5-year history
- 27th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.95
- Correlation with S&P 500
- 0.26
- Current drawdown from 1-year high
- -67.4%
- Maximum drawdown, 3 years
- -78.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 16, 2021 | May 23, 2025 | -99.3% | 1073 days | Not yet recovered |
| Dec 28, 2020 | Jan 29, 2021 | -50.7% | 22 days | 3 days (Feb 3, 2021) |
| Feb 3, 2021 | Feb 5, 2021 | -18.8% | 2 days | 6 days (Feb 16, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $52.1M
- EPS, diluted (TTM)
- -$3.55
- Revenue (TTM)
- $197,000
- 52-week range
- $3.25 – $13.50
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $723,000 | $473,000 | $654,000 | $342,000 | $200,000 |
| Gross profit | $434,000 | $447,000 | $533,000 | $272,000 | $157,000 |
| Operating income | -$50.0M | -$48.4M | -$40.5M | -$33.1M | -$23.1M |
| Net income | -$9.7M | -$29.9M | -$49.5M | -$39.4M | -$26.2M |
| EPS (diluted) | -$3.16 | -$4.69 | -$9.43 | -$5.67 | -$2.65 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $87,000 | $91,000 | $81,000 | $27,000 | $15,000 | $77,000 | $15,000 | $90,000 |
| Net income | -$8.0M | -$13.5M | -$751,000 | -$7.4M | -$8.8M | -$9.2M | -$8.1M | -$13.4M |
| EPS (diluted) | -$1.22 | -$1.95 | -$0.09 | -$0.78 | -$0.85 | -$0.93 | -$0.69 | -$1.08 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$34.6M | -$39.0M | -$30.2M | -$21.3M | -$18.5M |
| Capital expenditure | -$1.3M | -$5.2M | -$330,000 | -$15,000 | -$39,000 |
| Free cash flow | -$36.0M | -$44.2M | -$30.5M | -$21.3M | -$18.6M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $9.3M | $11.5M | $42.1M | $9.2M | $10.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $9.7M
- Total assets
- $23.0M
- Total liabilities
- $47.8M
- Total debt
- $22.3M
- Net debt
- $12.7M
- Shareholders’ equity
- -$24.8M
As of Jun 30, 2026 (filed Aug 14, 2026).
Short interest
- Shares sold short
- 915,634
- Days to cover
- 5.15
- Change vs previous report
- -5.2%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jul 11, 2024
- 1-for-20